Bivalirudin versus Heparin Monotherapy in Myocardial Infarction | Zendy

David Erlinge | Zendy; Elmir Ömerovic | Zendy; Ole Frøbert | Zendy; Rikard Linder | Zendy; Mikael Danielewicz | Zendy; Mehmet Hamid | Zendy; Eva Swahn | Zendy; Loghman Henareh | Zendy; Henrik Wagner | Zendy; Peter Hårdhammar | Zendy; Iwar Sjögren | Zendy; Jason Stewart | Zendy; Per Grimfjärd | Zendy; Jens Jensen | Zendy; Mikael Aasa | Zendy; Lotta Robertsson | Zendy; Pontus Lindroos | Zendy; Jan Haupt | Zendy; Helena Wikström | Zendy; Anders Ulvenstam | Zendy; Pallonji Bhiladvala | Zendy; Bo Lindvall | Zendy; Anders Lundin | Zendy; Tim Tödt | Zendy; Dan Ioanes | Zendy; Truls Råmunddal | Zendy; Thomas Kellerth | Zendy; Leszek Zagozdzon | Zendy; Matthias Götberg | Zendy; Jonas Andersson | Zendy; Oskar Angerås | Zendy; Ollie Östlund | Zendy; Bo Lagerqvist | Zendy; Claes Held | Zendy; Lars Wallentin | Zendy; Fredrik Scherstén | Zendy; Peter Eriksson | Zendy; Sasha Koul | Zendy; Stefan James | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

Author(s) -

David Erlinge,

Elmir Ömerovic,

Ole Frøbert,

Rikard Linder,

Mikael Danielewicz,

Mehmet Hamid,

Eva Swahn,

Loghman Henareh,

Henrik Wagner,

Peter Hårdhammar,

Iwar Sjögren,

Jason Stewart,

Per Grimfjärd,

Jens Jensen,

Mikael Aasa,

Lotta Robertsson,

Pontus Lindroos,

Jan Haupt,

Helena Wikström,

Anders Ulvenstam,

Pallonji Bhiladvala,

Bo Lindvall,

Anders Lundin,

Tim Tödt,

Dan Ioanes,

Truls Råmunddal,

Thomas Kellerth,

Leszek Zagozdzon,

Matthias Götberg,

Jonas Andersson,

Oskar Angerås,

Ollie Östlund,

Bo Lagerqvist,

Claes Held,

Lars Wallentin,

Fredrik Scherstén,

Peter Eriksson,

Sasha Koul,

Stefan James

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1706443

Subject(s) - medicine , bivalirudin , conventional pci , percutaneous coronary intervention , myocardial infarction , heparin , cardiology

The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) according to current practice, which includes the use of radial-artery access for PCI and administration of potent P2Y 12 inhibitors without the planned use of glycoprotein IIb/IIIa inhibitors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research